Journal
EXPERT REVIEW OF PROTEOMICS
Volume 7, Issue 4, Pages 495-506Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/EPR.10.45
Keywords
chemical chaperones; cystic fibrosis transmembrane conductance regulator; protein biogenesis; proteome; readthrough
Categories
Funding
- NIH [DK060065, HL076587]
- American Lung Association [RG-82840N]
Ask authors/readers for more resources
Proteomic analysis has proved to be an important tool for understanding the complex nature of genetic disorders, such as cystic fibrosis (CF), by defining the cellular protein environment (proteome) associated with wild-type and mutant proteins. Proteomic screens identified the proteome of CF transmembrane conductance regulator (CFTR), and provided fundamental information to studies designed for understanding the crucial components of physiological CFTR function. Simultaneously, high-throughput screens for small-molecular correctors of CFTR mutants provided promising candidates for therapy. The majority of CF cases are caused by nucleotide deletions (Delta F508 CFTR; >75%), resulting in CFTR misfolding, or insertion of premature termination codons (similar to 10%), leading to unstable mRNA and reduced levels of truncated dysfunctional CFTR. In this article, we review recent results of proteomic screens, developments in identifying correctors for the most frequent CFTR mutants, and comment on how integration of the knowledge gained from these studies may aid in finding a cure for CF and a number of other genetic disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available